Orgenesis Inc

+0.04 (+7.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.24M
Current PEN/A
Forward PE 3
2yr Forward PE 1.03
See more stats
Estimates Current Quarter
Revenue$13.5 Million
Adjusted EPS$0.10
See more estimates
10-Day MA$0.66
50-Day MA$0.87
200-Day MA$1.40
See more pivots

Orgenesis Inc Stock, NASDAQ:ORGS

20271 Goldenrod Lane, 20271 Goldenrod Lane, Germantown, Maryland 20876
United States of America
Phone: +1.480.659.6404
Number of Employees: 167


Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.